PGC-1α, SIRT1 and AMPK, an energy sensing network that controls energy expenditure

DeFronzo, 1982, Hepatic and peripheral insulin resistance: a common feature of type 2 (noninsulin-dependent) and type 1 (insulin-dependent) diabetes mellitus, Diabetologia, 23, 313, 10.1007/BF00253736

Lillioja, 1988, Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians, N Engl J Med, 318, 1217, 10.1056/NEJM198805123181901

Kelley, 1994, Impaired free fatty acid utilization by skeletal muscle in noninsulin-dependent diabetes mellitus, J Clin Invest, 94, 2349, 10.1172/JCI117600

He, 2001, Skeletal muscle lipid content and oxidative enzyme activity in relation to muscle fiber type in type 2 diabetes and obesity, Diabetes, 50, 817, 10.2337/diabetes.50.4.817

Simoneau, 1997, Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM, J Appl Physiol, 83, 166, 10.1152/jappl.1997.83.1.166

Bachmann, 2001, Effects of intravenous and dietary lipid challenge on intramyocellular lipid content and the relation with insulin sensitivity in humans, Diabetes, 50, 2579, 10.2337/diabetes.50.11.2579

Boden, 2001, Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects, Diabetes, 50, 1612, 10.2337/diabetes.50.7.1612

Itani, 2002, Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha, Diabetes, 51, 2005, 10.2337/diabetes.51.7.2005

Kelley, 2000, Fuel selection in human skeletal muscle in insulin resistance: a reexamination, Diabetes, 49, 677, 10.2337/diabetes.49.5.677

Petersen, 2003, Mitochondrial dysfunction in the elderly: possible role in insulin resistance, Science, 300, 1140, 10.1126/science.1082889

Petersen, 2004, Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes, N Engl J Med, 350, 664, 10.1056/NEJMoa031314

Szendroedi, 2007, Muscle mitochondrial ATP synthesis and glucose transport/phosphorylation in type 2 diabetes, PLoS Med, 4, e154, 10.1371/journal.pmed.0040154

Schrauwen-Hinderling, 2007, Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects, Diabetologia, 50, 113, 10.1007/s00125-006-0475-1

Rabol, 2006, Mitochondrial oxidative function and type 2 diabetes, Appl Physiol Nutr Metab, 31, 675, 10.1139/h06-071

Patti, 2003, Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1, Proc Natl Acad Sci U S A, 100, 8466, 10.1073/pnas.1032913100

Mootha, 2003, PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes, Nat Genet, 34, 267, 10.1038/ng1180

Tanner, 2002, Muscle fiber type is associated with obesity and weight loss, Am J Physiol Endocrinol Metab, 282, E1191, 10.1152/ajpendo.00416.2001

Hom, 1984, Insulin dose-response characteristics among individual muscle and adipose tissues measured in the rat in vivo with 3[H]2-deoxyglucose, Diabetes, 33, 153, 10.2337/diab.33.2.153

DeFronzo, 1981, The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterisation, Diabetes, 30, 1000, 10.2337/diab.30.12.1000

Puigserver, 1998, A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis, Cell, 92, 829, 10.1016/S0092-8674(00)81410-5

Feige, 2007, Transcriptional coregulators in the control of energy homeostasis, Trends Cell Biol, 17, 292, 10.1016/j.tcb.2007.04.001

Wu, 1999, Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1, Cell, 98, 115, 10.1016/S0092-8674(00)80611-X

St-Pierre, 2003, Bioenergetic analysis of peroxisome proliferator-activated receptor gamma coactivators 1alpha and 1beta (PGC-1alpha and PGC-1beta) in muscle cells, J Biol Chem, 278, 26597, 10.1074/jbc.M301850200

Lehman, 2000, Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis, J Clin Invest, 106, 847, 10.1172/JCI10268

Vega, 2000, The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes, Mol Cell Biol, 20, 1868, 10.1128/MCB.20.5.1868-1876.2000

Wang, 2003, Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity, Cell, 113, 159, 10.1016/S0092-8674(03)00269-1

Huss, 2002, Peroxisome proliferator-activated receptor coactivator-1alpha (PGC-1alpha) coactivates the cardiac-enriched nuclear receptors estrogen-related receptor-alpha and -gamma. Identification of novel leucine-rich interaction motif within PGC-1alpha, J Biol Chem, 277, 40265, 10.1074/jbc.M206324200

Schreiber, 2003, The transcriptional coactivator PGC-1 regulates the expression and activity of the orphan nuclear receptor estrogen-related receptor alpha (ERRalpha), J Biol Chem, 278, 9013, 10.1074/jbc.M212923200

Michael, 2001, Restoration of insulin-sensitive glucose transporter (GLUT4) gene expression in muscle cells by the transcriptional coactivator PGC-1, Proc Natl Acad Sci U S A, 98, 3820, 10.1073/pnas.061035098

Puigserver, 2003, Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction, Nature, 423, 550, 10.1038/nature01667

Mootha, 2004, Erralpha and Gabpa/b specify PGC-1alpha-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle, Proc Natl Acad Sci U S A, 101, 6570, 10.1073/pnas.0401401101

Lin, 2002, Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres, Nature, 418, 797, 10.1038/nature00904

Handschin, 2007, Skeletal muscle fiber-type switching, exercise intolerance, and myopathy in PGC-1alpha muscle-specific knock-out animals, J Biol Chem, 282, 30014, 10.1074/jbc.M704817200

Richardson, 2005, Lipid infusion decreases the expression of nuclear encoded mitochondrial genes and increases the expression of extracellular matrix genes in human skeletal muscle, J Biol Chem, 280, 10290, 10.1074/jbc.M408985200

Ling, 2004, Multiple environmental and genetic factors influence skeletal muscle PGC-1alpha and PGC-1beta gene expression in twins, J Clin Invest, 114, 1518, 10.1172/JCI21889

Mensink, 2007, Improved skeletal muscle oxidative enzyme activity and restoration of PGC-1 alpha and PPAR beta/delta gene expression upon rosiglitazone treatment in obese patients with type 2 diabetes mellitus, Int J Obes (Lond), 31, 1302, 10.1038/sj.ijo.0803567

Esterbauer, 1999, Human peroxisome proliferator activated receptor gamma coactivator 1 (PPARGC1) gene: cDNA sequence, genomic organization, chromosomal localization, and tissue expression, Genomics, 62, 98, 10.1006/geno.1999.5977

Pratley, 1998, An autosomal genomic scan for loci linked to prediabetic phenotypes in Pima Indians, J Clin Invest, 101, 1757, 10.1172/JCI1850

Perusse, 2001, A genome-wide scan for abdominal fat assessed by computed tomography in the Quebec Family Study, Diabetes, 50, 614, 10.2337/diabetes.50.3.614

Stone, 2002, A major predisposition locus for severe obesity, at 4p15-p14, Am J Hum Genet, 70, 1459, 10.1086/340670

Arya, 2004, Evidence of a novel quantitative-trait locus for obesity on chromosome 4p in Mexican Americans, Am J Hum Genet, 74, 272, 10.1086/381717

Ek, 2001, Mutation analysis of peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to type II diabetes mellitus, Diabetologia, 44, 2220, 10.1007/s001250100032

Andrulionyte, 2004, Common polymorphisms of the PPAR-gamma2 (Pro12Ala) and PGC-1alpha (Gly482Ser) genes are associated with the conversion from impaired glucose tolerance to type 2 diabetes in the STOP-NIDDM trial, Diabetologia, 47, 2176, 10.1007/s00125-004-1577-2

Bhat, 2007, PGC-1alpha Thr394Thr and Gly482Ser variants are significantly associated with T2DM in two North Indian populations: a replicate case–control study, Hum Genet, 121, 609, 10.1007/s00439-007-0352-0

Hara, 2002, A genetic variation in the PGC-1 gene could confer insulin resistance and susceptibility to type II diabetes, Diabetologia, 45, 740, 10.1007/s00125-002-0803-z

Oberkofler, 2004, Complex haplotypes of the PGC-1alpha gene are associated with carbohydrate metabolism and type 2 diabetes, Diabetes, 53, 1385, 10.2337/diabetes.53.5.1385

Stumvoll, 2004, The Gly482Ser variant in the peroxisome proliferator-activated receptor gamma coactivator-1 is not associated with diabetes-related traits in nondiabetic German and Dutch populations, Exp Clin Endocrinol Diabetes, 112, 253, 10.1055/s-2004-817972

Puigserver, 2001, Cytokine stimulation of energy expenditure through p38 MAP kinase activation of PPARgamma coactivator-1, Mol Cell, 8, 971, 10.1016/S1097-2765(01)00390-2

Jager, 2007, AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha, Proc Natl Acad Sci U S A, 104, 12017, 10.1073/pnas.0705070104

Li, 2007, Akt/PKB regulates hepatic metabolism by directly inhibiting PGC-1alpha transcription coactivator, Nature, 447, 1012, 10.1038/nature05861

Rodgers, 2005, Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1, Nature, 434, 113, 10.1038/nature03354

Nemoto, 2005, SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1{alpha}, J Biol Chem, 280, 16456, 10.1074/jbc.M501485200

Lagouge, 2006, Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha, Cell, 127, 1109, 10.1016/j.cell.2006.11.013

Teyssier, 2005, Activation of nuclear receptor coactivator PGC-1alpha by arginine methylation, Genes Dev, 19, 1466, 10.1101/gad.1295005

Rodgers, 2008, Metabolic adaptations through the PGC-1 alpha and SIRT1 pathways, FEBS Lett, 582, 46, 10.1016/j.febslet.2007.11.034

Fan, 2004, Suppression of mitochondrial respiration through recruitment of p160 myb binding protein to PGC-1alpha: modulation by p38 MAPK, Genes Dev, 18, 278, 10.1101/gad.1152204

Cooper, 2006, Defects in energy homeostasis in Leigh syndrome French Canadian variant through PGC-1alpha/LRP130 complex, Genes Dev, 20, 2996, 10.1101/gad.1483906

Picard, 2002, SRC-1 and TIF2 control energy balance between white and brown adipose tissues, Cell, 111, 931, 10.1016/S0092-8674(02)01169-8

Puigserver, 1999, Activation of PPARgamma coactivator-1 through transcription factor docking, Science, 286, 1368, 10.1126/science.286.5443.1368

Lin, 2004, Calorie restriction extends yeast life span by lowering the level of NADH, Genes Dev, 18, 12, 10.1101/gad.1164804

Anderson, 2002, Manipulation of a nuclear NAD+ salvage pathway delays aging without altering steady-state NAD+ levels, J Biol Chem, 277, 18881, 10.1074/jbc.M111773200

Yang, 2007, SIRT1 sumoylation regulates its deacetylase activity and cellular response to genotoxic stress, Nat Cell Biol, 9, 1253, 10.1038/ncb1645

Kim, 2008, DBC1 is a negative regulator of SIRT1, Nature, 451, 583, 10.1038/nature06500

Zhao, 2008, Negative regulation of the deacetylase SIRT1 by DBC1, Nature, 451, 587, 10.1038/nature06515

Kim, 2007, Active regulator of SIRT1 cooperates with SIRT1 and facilitates suppression of p53 activity, Mol Cell, 28, 277, 10.1016/j.molcel.2007.08.030

Picard, 2004, Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma, Nature, 429, 771, 10.1038/nature02583

Vaziri, 2001, hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase, Cell, 107, 149, 10.1016/S0092-8674(01)00527-X

Brunet, 2004, Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase, Science, 303, 2011, 10.1126/science.1094637

Pagans, 2005, SIRT1 regulates HIV transcription via Tat deacetylation, PLoS Biol, 3, e41, 10.1371/journal.pbio.0030041

Hallows, 2006, Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases, Proc Natl Acad Sci U S A, 103, 10230, 10.1073/pnas.0604392103

Lerin, 2006, GCN5 acetyltransferase complex controls glucose metabolism through transcriptional repression of PGC-1alpha, Cell Metab, 3, 429, 10.1016/j.cmet.2006.04.013

Coste, 2008, The genetic ablation of SRC-3 protects against obesity and improves insulin sensitivity by reducing the acetylation of PGC-1{alpha}, Proc Natl Acad Sci U S A, 105, 17187, 10.1073/pnas.0808207105

Gerhart-Hines, 2007, Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha, Embo J, 26, 1913, 10.1038/sj.emboj.7601633

Rodgers, 2007, Fasting-dependent glucose and lipid metabolic response through hepatic sirtuin 1, Proc Natl Acad Sci U S A, 104, 12861, 10.1073/pnas.0702509104

Liu, 2008, A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange, Nature, 456, 269, 10.1038/nature07349

Cheng, 2003, Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice, Proc Natl Acad Sci U S A, 100, 10794, 10.1073/pnas.1934713100

McBurney, 2003, The mammalian SIR2alpha protein has a role in embryogenesis and gametogenesis, Mol Cell Biol, 23, 38, 10.1128/MCB.23.1.38-54.2003

Banks, 2008, SirT1 gain of function increases energy efficiency and prevents diabetes in mice, Cell Metab, 8, 333, 10.1016/j.cmet.2008.08.014

Bordone, 2007, SIRT1 transgenic mice show phenotypes resembling calorie restriction, Aging Cell, 6, 759, 10.1111/j.1474-9726.2007.00335.x

Milne, 2007, Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes, Nature, 450, 712, 10.1038/nature06261

Chen, 2008, Tissue-specific regulation of SIRT1 by calorie restriction, Genes Dev, 22, 1753, 10.1101/gad.1650608

Hardie, 2007, AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy, Nat Rev Mol Cell Biol, 8, 774, 10.1038/nrm2249

Ojuka, 2000, Increased expression of GLUT-4 and hexokinase in rat epitrochlearis muscles exposed to AICAR in vitro, J Appl Physiol, 88, 1072, 10.1152/jappl.2000.88.3.1072

Winder, 2000, Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle, J Appl Physiol, 88, 2219, 10.1152/jappl.2000.88.6.2219

Zhou, 2001, Role of AMP-activated protein kinase in mechanism of metformin action, J Clin Invest, 108, 1167, 10.1172/JCI13505

Zong, 2002, AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation, Proc Natl Acad Sci U S A, 99, 15983, 10.1073/pnas.252625599

Long, 2005, Role of AMP-activated protein kinase in the coordinated expression of genes controlling glucose and lipid metabolism in mouse white skeletal muscle, Diabetologia, 48, 2354, 10.1007/s00125-005-1962-5

Barnes, 2005, Changes in exercise-induced gene expression in 5′-AMP-activated protein kinase gamma3-null and gamma3 R225Q transgenic mice, Diabetes, 54, 3484, 10.2337/diabetes.54.12.3484

Garcia-Roves, 2008, Gain-of-function R225Q mutation in AMP-activated protein kinase gamma 3 subunit increases mitochondrial biogenesis in glycolytic skeletal muscle, J Biol Chem, 283, 35724, 10.1074/jbc.M805078200

Barnes, 2004, The 5′-AMP-activated protein kinase gamma3 isoform has a key role in carbohydrate and lipid metabolism in glycolytic skeletal muscle, J Biol Chem, 279, 38441, 10.1074/jbc.M405533200

Narkar, 2008, AMPK and PPARdelta agonists are exercise mimetics, Cell, 134, 405, 10.1016/j.cell.2008.06.051

Cool, 2006, Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome, Cell Metab, 3, 403, 10.1016/j.cmet.2006.05.005

Suwa, 2003, Effects of chronic AICAR treatment on fiber composition, enzyme activity, UCP3, and PGC-1 in rat muscles, J Appl Physiol, 95, 960, 10.1152/japplphysiol.00349.2003

Terada, 2002, Effects of low-intensity prolonged exercise on PGC-1 mRNA expression in rat epitrochlearis muscle, Biochem Biophys Res Commun, 296, 350, 10.1016/S0006-291X(02)00881-1